Beijing Konruns Pharmaceutical Co.,Ltd. (SHSE: 603590)
Health Care · Pharmaceuticals · CN
CN¥32.21
-1.59% today · -39.2% 1Y
Beijing Konruns Pharmaceutical Co.,Ltd. (SHSE: 603590) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $754.82M and employs 793 people.
Over the last twelve months the share price has lost 39.2%, trading between 27.33 and 65.50.
Tweenvest scores Beijing Konruns Pharmaceutical Co.,Ltd. across four factors: quality 74/100, value 55/100, growth 24/100, dividend 26/100. Its strongest factor is quality.
603590 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $754.82M
- Revenue (TTM)
- $133.09M
- P/E
- 30.40
- EPS
- 1.06
- Dividend yield
- 1.09%
- Beta (5Y)
- 0.40
- 52-week high
- CN¥65.50
- 52-week low
- CN¥27.33
- Avg volume (3M)
- —
- Shares outstanding
- 157.53M
- Employees
- 793
- Next earnings
- —
About Beijing Konruns Pharmaceutical Co.,Ltd.
Beijing Konruns Pharmaceutical Co.,Ltd., a Chinese company established in 2003 and based in Beijing, focuses on the discovery, production, and distribution of various pharmaceutical items. Among its key offerings is Su Ling, a hemagglutinin preparation designed to minimize blood loss during surgical procedures and manage post-operative bleeding. The firm is also actively developing a pipeline of potential new medicines, such as CX1026, CX1003, and KC1036.
- ISIN
- CNE1000036K3
- Founded
- 2003
- Listed since
- Aug 27, 2018
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.